Reloading When Switching From Ticagrelor or Prasugrel to Clopidogrel Within 7 Days After STEMI

JACC Cardiovasc Interv. 2020 Mar 9;13(5):663-665. doi: 10.1016/j.jcin.2020.01.001.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Decision-Making
  • Clopidogrel / administration & dosage*
  • Clopidogrel / adverse effects
  • Coronary Thrombosis / diagnostic imaging
  • Coronary Thrombosis / etiology
  • Coronary Thrombosis / prevention & control*
  • Drug Substitution* / adverse effects
  • Hemorrhage / chemically induced
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Prasugrel Hydrochloride / administration & dosage*
  • Prasugrel Hydrochloride / adverse effects
  • Risk Assessment
  • Risk Factors
  • ST Elevation Myocardial Infarction / diagnostic imaging
  • ST Elevation Myocardial Infarction / therapy*
  • Ticagrelor / administration & dosage*
  • Ticagrelor / adverse effects
  • Time Factors
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Prasugrel Hydrochloride
  • Ticagrelor